On Tuesday, October 29, Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences, who served as administrator of CMS under ...
Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist
Cost-effectiveness analyzes (CEA) aim to examine how new healthcare technologies impact health outcomes and costs throughout a patient's life. While it is ...
That's the clever title of recient American Economic Review post by Cyrus Aghamolla, Pinar Karaca-Mandic, Xuelin Li, ...
Scoping reviews are a type of knowledge synthesis, following a systematic approach to mapping the evidence on a topic and ...
Randomized controlled trials are the gold standard for evaluating treatment effectiveness, but real-world effectiveness may vary. One reason for this is ...
That is the title of a KFF article published last week. Results are based on KFF. 2024 Employer Health Benefits Survey. ...
In a press release dated October 16, the US Department of Health and Human Services (HHS)through the Centers for Medicare and Medicaid Services (CMS)announced ...
This year the Nobel Prize in Medicine went to Victor Ambros, currently Professor of Natural Sciences at the University of ...
Recently, the Office of Management and Budget has published new procedures for evaluating government regulation (Circular A-4) and economic policies ...
Paxlovid (nirmatrelvir-ritonavir) is effective in preventing hospitalization and death from COVID-19, but few people use ...
- 1
- 2
- 3
- …
- 14
- Next Page »